Propulia Capital (investor - Venture Capital)

Canada
See something wrong or missing? Let us know
Offices:Quebec
Average round investment:15.01M USD
Average number per year:1.0
Distribution: 2023 (1)
Portfolio companies: France Kiro
Mostly invests in: France France (1) Biotech (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Propulia Capital

Name Criteria
France Nabuboto
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Financière Arbevel
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Sweden Niklas Zennström
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
France Siparex
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Xerys
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France eureKARE
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland Céleste Management Sa
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Denmark Novo Seeds
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
Switzerland Debiopharm Innovation Fund
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Bengt Julander
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top